Categories Technology

Citron sends a shockwave: Panicked investors dump Shopify

Shopify (NYSE: SHOP) stock was trending during intra-day trading on Thursday, with over 2.87 million shares changing hands. The high-volume sell-off was spurred by bearish outlook given by research firm Citron on the stock.

Setting the 12-month price target on the stock at $100, Citron said it sees “drastic changes” in Shopify’s competitive landscape, which could hinder the company’s growth prospects.

The research firm was referring to reports that bigger tech firms including Microsoft (MSFT) or Facebook (FB) could soon be bringing out similar services, which in turn would eat into Shopify’s market share.

The short recommendation sent SHOP shares down over 6%. In the trailing 52 weeks period, the stock has gained 61%.

READ: LYFT AND SIX OTHER COMPANIES WENT PUBLIC IN MARCH. FULL LIST

This is the second time in the past three years that SHOP shares have suffered due to caution from Citron. The first stock plummet happened in the rear half of 2017. However, the stock rebounded soon after, thanks to the confidence of institutional investors including BNY Mellon, T. Rowe Price, and Fidelity Investments.

Investors have recently been worried about the deceleration in Shopify’s top line. In February, despite reporting market-beating fourth-quarter results, shares of Shopify (SHOP) fell over 6%, on the same reason.

Revenue for the quarter jumped 54% to $343.9 million, beating the market consensus. But the 54% increase in Q4 revenue marks the fourth consecutive quarter of growth rate decline. Revenue growth has consistently declined in the past three quarters, registering at 68% in Q1, 62% in Q2 and 58% in Q3.

 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top